APO RESEARCH · REPORT
Antacid
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
Product & engineering
Understand the product.
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
Selected research
Industry Research
Antacid Industry Research Report 2026
Market perspective
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
Read the full market overview
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
Report Scope
This report quantifies the global Antacid market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antacid Market by Company
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter＆Gamble
GlaxoSmithKline
Johnson＆Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Reddy's Laboratories
Antacid Segment by Type
Proton Pump Inhibitor
H2 Antagonist
Acid Neutralizers
Antacid Segment by Application
OTC Drug
Rx Drug
Antacid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antacid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antacid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antacid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antacid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Proton Pump Inhibitor
- H2 Antagonist
- Acid Neutralizers
Applications
- OTC Drug
- Rx Drug
Companies covered
- AstraZeneca
- Takeda Pharmaceutical
- Pfizer
- Reckitt Benckiser
- Bayer
- Procter＆Gamble
- GlaxoSmithKline
- Johnson＆Johnson
- CONBA
- Xiuzheng Pharma
- Sanofi
- Bausch Health
- CR SANJIU
- Reddy's Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antacid Market Size (2021-2032)
- 2.2.2 Global Antacid Sales (2021-2032)
- 2.2.3 Global Antacid Market Average Price (2021-2032)
- 2.3 Antacid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Proton Pump Inhibitor
- 2.3.3 H2 Antagonist
- 2.3.4 Acid Neutralizers
- 2.4 Antacid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 OTC Drug
- 2.4.3 Rx Drug
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antacid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antacid Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Antacid Revenue of Manufacturers (2021-2026)
- 3.4 Global Antacid Average Price by Manufacturers (2021-2026)
- 3.5 Global Antacid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antacid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antacid, Product Type & Application
- 3.8 Global Manufacturers of Antacid, Established Date
- 3.9 Global Antacid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AstraZeneca
- 4.1.1 AstraZeneca Company Information
- 4.1.2 AstraZeneca Business Overview
- 4.1.3 AstraZeneca Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AstraZeneca Antacid Product Portfolio
- 4.1.5 AstraZeneca Recent Developments
- 4.2 Takeda Pharmaceutical
- 4.2.1 Takeda Pharmaceutical Company Information
- 4.2.2 Takeda Pharmaceutical Business Overview
- 4.2.3 Takeda Pharmaceutical Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Pharmaceutical Antacid Product Portfolio
- 4.2.5 Takeda Pharmaceutical Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Antacid Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Reckitt Benckiser
- 4.4.1 Reckitt Benckiser Company Information
- 4.4.2 Reckitt Benckiser Business Overview
- 4.4.3 Reckitt Benckiser Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Reckitt Benckiser Antacid Product Portfolio
- 4.4.5 Reckitt Benckiser Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Antacid Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Procter＆Gamble
- 4.6.1 Procter＆Gamble Company Information
- 4.6.2 Procter＆Gamble Business Overview
- 4.6.3 Procter＆Gamble Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Procter＆Gamble Antacid Product Portfolio
- 4.6.5 Procter＆Gamble Recent Developments
- 4.7 GlaxoSmithKline
- 4.7.1 GlaxoSmithKline Company Information
- 4.7.2 GlaxoSmithKline Business Overview
- 4.7.3 GlaxoSmithKline Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GlaxoSmithKline Antacid Product Portfolio
- 4.7.5 GlaxoSmithKline Recent Developments
- 4.8 Johnson＆Johnson
- 4.8.1 Johnson＆Johnson Company Information
- 4.8.2 Johnson＆Johnson Business Overview
- 4.8.3 Johnson＆Johnson Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Johnson＆Johnson Antacid Product Portfolio
- 4.8.5 Johnson＆Johnson Recent Developments
- 4.9 CONBA
- 4.9.1 CONBA Company Information
- 4.9.2 CONBA Business Overview
- 4.9.3 CONBA Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 CONBA Antacid Product Portfolio
- 4.9.5 CONBA Recent Developments
- 4.10 Xiuzheng Pharma
- 4.10.1 Xiuzheng Pharma Company Information
- 4.10.2 Xiuzheng Pharma Business Overview
- 4.10.3 Xiuzheng Pharma Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Xiuzheng Pharma Antacid Product Portfolio
- 4.10.5 Xiuzheng Pharma Recent Developments
- 4.11 Sanofi
- 4.11.1 Sanofi Company Information
- 4.11.2 Sanofi Business Overview
- 4.11.3 Sanofi Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sanofi Antacid Product Portfolio
- 4.11.5 Sanofi Recent Developments
- 4.12 Bausch Health
- 4.12.1 Bausch Health Company Information
- 4.12.2 Bausch Health Business Overview
- 4.12.3 Bausch Health Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bausch Health Antacid Product Portfolio
- 4.12.5 Bausch Health Recent Developments
- 4.13 CR SANJIU
- 4.13.1 CR SANJIU Company Information
- 4.13.2 CR SANJIU Business Overview
- 4.13.3 CR SANJIU Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 CR SANJIU Antacid Product Portfolio
- 4.13.5 CR SANJIU Recent Developments
- 4.14 Reddy's Laboratories
- 4.14.1 Reddy's Laboratories Company Information
- 4.14.2 Reddy's Laboratories Business Overview
- 4.14.3 Reddy's Laboratories Antacid Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Reddy's Laboratories Antacid Product Portfolio
- 4.14.5 Reddy's Laboratories Recent Developments
5 Global Antacid Market Scenario by Region
- 5.1 Global Antacid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antacid Sales by Region: 2021-2032
- 5.2.1 Global Antacid Sales by Region: 2021-2026
- 5.2.2 Global Antacid Sales by Region: 2027-2032
- 5.3 Global Antacid Revenue by Region: 2021-2032
- 5.3.1 Global Antacid Revenue by Region: 2021-2026
- 5.3.2 Global Antacid Revenue by Region: 2027-2032
- 5.4 North America Antacid Market Facts & Figures by Country
- 5.4.1 North America Antacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antacid Sales by Country (2021-2032)
- 5.4.3 North America Antacid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antacid Market Facts & Figures by Country
- 5.5.1 Europe Antacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antacid Sales by Country (2021-2032)
- 5.5.3 Europe Antacid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antacid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antacid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antacid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antacid Market Facts & Figures by Country
- 5.7.1 South America Antacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antacid Sales by Country (2021-2032)
- 5.7.3 South America Antacid Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Antacid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antacid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antacid Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antacid Sales by Type (2021-2032)
- 6.1.1 Global Antacid Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Antacid Sales Market Share by Type (2021-2032)
- 6.2 Global Antacid Revenue by Type (2021-2032)
- 6.2.1 Global Antacid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antacid Revenue Market Share by Type (2021-2032)
- 6.3 Global Antacid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antacid Sales by Application (2021-2032)
- 7.1.1 Global Antacid Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Antacid Sales Market Share by Application (2021-2032)
- 7.2 Global Antacid Revenue by Application (2021-2032)
- 7.2.1 Global Antacid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antacid Revenue Market Share by Application (2021-2032)
- 7.3 Global Antacid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antacid Value Chain Analysis
- 8.1.1 Antacid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antacid Production Mode & Process
- 8.2 Antacid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antacid Distributors
- 8.2.3 Antacid Customers
9 Global Antacid Analyzing Market Dynamics
- 9.1 Antacid Industry Trends
- 9.2 Antacid Industry Drivers
- 9.3 Antacid Industry Opportunities and Challenges
- 9.4 Antacid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst